Stephanie M.

Stephanie M. currently serves as the Senior Director of Pharmacology at Delix Therapeutics, a position held since November 2023. Previously, Stephanie held multiple roles at Arkuda Therapeutics from September 2020 to November 2023, progressing from Associate Director to Director of Pharmacology. Prior experience includes a consultancy at Lucy Therapeutics and several key roles at Sage Therapeutics, Novartis, and Pfizer, where responsibilities varied from leading scientific teams to conducting advanced research in behavioral neuroscience. Education credentials include a BA, MPhil, and PhD in Natural Sciences and Behavioural Neuroscience from the University of Cambridge.